Doheny Asset Management /Ca Cyma Bay Therapeutics, Inc. Transaction History

Doheny Asset Management /Ca

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$1.33 - $5.93 $55,195 - $246,095	-41,500 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$5.12 - $7.21 $180,608 - $254,332	-35,275 Reduced 45.95%	41,500 $212,000
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $215,228 - $485,954	35,575 Added 86.35%	76,775 $550,000
Q1 2019 May 14, 2019	BUY	$8.16 - $13.42 $336,192 - $552,904	41,200 New	41,200 $547,000
Q4 2018 Feb 13, 2019	SELL	$6.54 - $11.74 $236,584 - $424,694	-36,175 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $393,584 - $525,261	36,175 New	36,175 $401,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

Stay updated on Doheny Asset Management /Ca with notifications on news.